Idzikowski C, Cowen P J, Nutt D, Mills F J
Clinical Pharmacology Unit, Janssen Pharmaceutical Ltd, Wantage, Oxon., UK.
Psychopharmacology (Berl). 1987;93(4):416-20. doi: 10.1007/BF00207228.
A previous study has shown that acute administration of the 5-HT2 receptor antagonist ritanserin doubles Slow Wave Sleep (SWS) and increases the prolactin (PRL) response to L-tryptophan (LTP). The present study investigated the effect of repeated ritanserin treatment on sleep, neuroendocrine response to LTP and 5-HT2 platelet receptor binding. After 2 weeks, ritanserin administration SWS was persistently increased but the PRL response to LTP was unchanged. Platelet 5-HT receptor binding was undetectable at the end of ritanserin treatment but recovered 2 weeks after drug withdrawal. The results suggest that ritanserin causes a sustained effect on the 5-HT mechanisms mediating SWS and on platelet 5-HT2 receptors. However, adaptation occurs to its effect on 5-HT-mediated neuroendocrine responses.
先前的一项研究表明,急性给予5-羟色胺2(5-HT2)受体拮抗剂利坦色林可使慢波睡眠(SWS)增加一倍,并增强催乳素(PRL)对L-色氨酸(LTP)的反应。本研究调查了重复给予利坦色林对睡眠、对LTP的神经内分泌反应以及5-HT2血小板受体结合的影响。两周后,给予利坦色林可使SWS持续增加,但PRL对LTP的反应未改变。在利坦色林治疗结束时,血小板5-HT受体结合无法检测到,但在停药2周后恢复。结果表明,利坦色林对介导SWS的5-HT机制和血小板5-HT2受体有持续影响。然而,其对5-HT介导的神经内分泌反应的作用会出现适应性变化。